Eikon Therapeutics | ApexOnco - Clinical Trials news and analysis

x

“It's very intuitive and always up-to-date”

Monika Vogelmann

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Trial results

14 February 2024

Venture cash funds first human trials

Private company trial initiations stand out in the latest week’s disclosures.

Subscribe to Eikon Therapeutics